{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:07:49Z","timestamp":1785190069832,"version":"3.55.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/infdis\/jix117","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T04:13:05Z","timestamp":1488600785000},"page":"S1-S8","source":"Crossref","is-referenced-by-count":31,"title":["Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future"],"prefix":"10.1093","volume":"216","author":[{"given":"Manish","family":"Patel","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cochi","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"key\n\t\t\t\t20180306121629_CIT0001","unstructured":"Global Polio Eradication Initiative. Wild poliovirus list. http:\/\/polioeradication.org\/polio-today\/polio-now\/wild-poliovirus-list\/. Accessed 16 February 2017."},{"key":"key\n\t\t\t\t20180306121629_CIT0002","first-page":"1","article-title":"Poliomyelitis","volume-title":"Immunological basis for immunization","author":"Robertson","year":"2001"},{"key":"key\n\t\t\t\t20180306121629_CIT0003","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/B978-1-4557-0090-5.00035-5","article-title":"Poliovirus vaccine - live","volume-title":"Vaccines","author":"Sutter","year":"2013","edition":"6th"},{"key":"key\n\t\t\t\t20180306121629_CIT0004","unstructured":"Global Polio Eradication Initiative. Global eradication of wild poliovirus type 2 declared. http:\/\/polioeradication.org\/news-post\/global-eradication-of-wild-poliovirus-type-2-declared\/. Accessed 16 February 2017."},{"key":"key\n\t\t\t\t20180306121629_CIT0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0006","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180306121629_CIT0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.109.2822.85","article-title":"Cultivation of the lansing strain of poliomyelitis virus in cultures of various human embryonic tissues","volume":"109","author":"Enders","year":"1949","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.5123.663","article-title":"Present position of immunization against poliomyelitis with live virus vaccines","volume":"1","author":"Sabin","year":"1959","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20180306121629_CIT0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2105\/AJPH.44.5.563","article-title":"Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines","volume":"44","author":"Salk","year":"1954","journal-title":"Am J Public Health Nations Health"},{"key":"key\n\t\t\t\t20180306121629_CIT0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0011","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biologicals.2006.02.012","article-title":"Interrupting poliovirus transmission \u2013 new solutions to an old problem","volume":"34","author":"Aylward","year":"2006","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20180306121629_CIT0012","first-page":"293","article-title":"Certification of poliomyelitis eradication-the Americas, 1994","volume":"69","author":"Expanded programme on immunization","year":"1994","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0013","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0014","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/B978-1-4557-0090-5.00034-3","article-title":"Poliovirus vaccine - Inactivated","volume-title":"Vaccine","author":"Vidor","year":"2013","edition":"6th"},{"key":"key\n\t\t\t\t20180306121629_CIT0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-7091-9278-8_23","article-title":"Inactivated and live, attenuated poliovirus vaccines:mucosal immunity","volume-title":"Measles and poliomyelitis","author":"Sutter","year":"1993"},{"key":"key\n\t\t\t\t20180306121629_CIT0016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0140-6736(90)90945-2","article-title":"Polio vaccines: time for a change in immunisation policy?","volume":"335","author":"Beale","year":"1990","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121629_CIT0017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(199707)7:2<83::AID-RMV193>3.0.CO;2-Q","article-title":"Developed countries should not use inactivated polio vaccine for the prevention of poliomyelitis","volume":"7","author":"Henderson","year":"1997","journal-title":"Rev Med Virol"},{"key":"key\n\t\t\t\t20180306121629_CIT0018","first-page":"252","article-title":"Problems with oral poliovaccine in India","volume":"9","author":"John","year":"1972","journal-title":"Indian Pediatr"},{"key":"key\n\t\t\t\t20180306121629_CIT0019","first-page":"129","article-title":"Methods for poliomyelitis eradication: is there a consensus?","volume":"21","author":"Beale","year":"1993","journal-title":"Public Health Rev"},{"key":"key\n\t\t\t\t20180306121629_CIT0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(96)91194-0","article-title":"Sabin, Salk, or sequential?","volume":"347","author":"Hull","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121629_CIT0021","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(94)92472-4","article-title":"Paralytic poliomyelitis: seasoned strategies, disappearing disease","volume":"343","author":"Hull","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121629_CIT0022","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/14760584.8.1.35","article-title":"Oral polio vaccines and their role in polio eradication in India","volume":"8","author":"Paul","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306121629_CIT0023","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference","volume":"96","author":"John","year":"1972","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180306121629_CIT0024","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/oxfordjournals.aje.a112180","article-title":"Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection","volume":"102","author":"John","year":"1975","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180306121629_CIT0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a112181","article-title":"Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response","volume":"102","author":"John","year":"1975","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20180306121629_CIT0026","first-page":"973","article-title":"Interrupting the transmission of wild polioviruses with vaccines: immunological considerations","volume":"72","author":"Ghendon","year":"1994","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121629_CIT0027","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(95)90305-4","article-title":"Polio eradication","volume":"345","author":"Ward","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121629_CIT0028","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1093\/infdis\/jit601","article-title":"Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis","volume":"210","author":"Grassly","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0029","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180306121629_CIT0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306121629_CIT0031","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1126\/science.277.5327.780","article-title":"Ending polio immunization","volume":"277","author":"Hull","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0032","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.277.5327.779","article-title":"The polio eradication effort: should vaccine eradication be next?","volume":"277","author":"Dove","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20180306121629_CIT0033","unstructured":"World Health Organization. Global eradication of poliomyelitis: report of the second meeting of the Global Technical Consultative Group (TCG), 28 April 1997. Available at http:\/\/apps.who.int\/iris\/bitstream\/10665\/63994\/1\/WHO_EPI_GEN_98.04.pdf (Last accessed, 16 February 2017)."},{"key":"key\n\t\t\t\t20180306121629_CIT0034","volume-title":"Cessation of routine oral polio vaccine (OPV) use after global polio eradication. Framework for national policy makers in OPV-using countries (WHO\/POLIO\/05.02)","author":"World Health Organization","year":"2005"},{"key":"key\n\t\t\t\t20180306121629_CIT0035","first-page":"201","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2012 - conclusions and recommendations","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0036","first-page":"72","article-title":"Technical Consultative Group to the World Health Organization on the Global Eradication of P. \u201cEndgame\u201d issues for the global polio eradication initiative","volume":"34","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0037","unstructured":"Global Polio Eradication Initiative. Polio Eradication and Endgame Strategic Plan 2013\u20132018. WHO\/POLIO\/13.02. Available at http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf 2013 (Last accessed, 14 February 2017)."},{"key":"key\n\t\t\t\t20180306121629_CIT0038","first-page":"347","article-title":"Stopping poliovirus vaccination after eradication: issues and challenges","volume":"78","author":"Wood","year":"2000","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121629_CIT0039","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"key\n\t\t\t\t20180306121629_CIT0040","first-page":"16","article-title":"Circulating vaccine-derived polioviruses: current state of knowledge","volume":"82","author":"Kew","year":"2004","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180306121629_CIT0041","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","article-title":"Polio endgame: the global switch from tOPV to bOPV","volume":"15","author":"Garon","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306121629_CIT0042","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0043","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMp1514467","article-title":"A world free of polio\u2014the final steps","volume":"374","author":"Patel","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180306121629_CIT0044","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/erv.11.195","article-title":"Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation","volume":"11","author":"Thompson","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180306121629_CIT0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/risa.12022","article-title":"Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs)","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121629_CIT0046","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1539-6924.2006.00827.x","article-title":"Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication","volume":"26","author":"Tebbens","year":"2006","journal-title":"Risk Anal"},{"key":"key\n\t\t\t\t20180306121629_CIT0047","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1093\/infdis\/jit845","article-title":"Modeling the dynamics of oral poliovirus vaccine cessation","volume":"210","author":"Thompson","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0048","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003","volume":"118","author":"Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"key\n\t\t\t\t20180306121629_CIT0049","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/514081","article-title":"Genetic analysis of wild-type poliovirus importation into the Netherlands (1979\u20131995)","volume":"176","author":"Mulders","year":"1997","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0050","unstructured":"World Health Organization. Strategic Advisory Group of Experts on immunization (SAGE) WHO, Geneva, 20\u201322 October 2015. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/october\/sage_report_oct_2015.pdf?ua=1 (Last accessed October 26, 2015)."},{"key":"key\n\t\t\t\t20180306121629_CIT0051","unstructured":"World Health Organization. Meeting of the SAGE Polio Working Group, WHO, Geneva, 7\u20138 September 2015. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2015\/october\/2_SAGE_WG_report_draft_Final_clean.pdf?ua=1 (Last accessed October 30, 2015)."},{"key":"key\n\t\t\t\t20180306121629_CIT0052","first-page":"1","article-title":"Meeting of the strategic advisory group of experts on immunization, November 2012 - conclusions and recommendations","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0053","first-page":"201","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2013 - conclusions and recommendations","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0054","first-page":"1","article-title":"Meeting of the strategic advisory group of experts on immunization, November 2013 -- conclusions and recommendations","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0055","first-page":"221","article-title":"Meeting of the strategic advisory group of experts on immunization, April 2014 -- conclusions and recommendations","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0056","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1093\/infdis\/jiu345","article-title":"Global polio eradication initiative: lessons learned and legacy","volume":"210","author":"Cochi","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0057","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw592","article-title":"Polio endgame: lessons learned from the immunization systems management group","author":"Zipursky","year":"2017; 216 ( 1):57\u201365.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0058","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw573","article-title":"Exceptional financial support for introduction of inactivated polio vaccine in Middle Income Countries","author":"Blankenhorn","year":"2017; 216 ( 1):9\u201314.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0059","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw577","article-title":"Financial support to eligible countries for the switch from trivalent to bivalent oral polio vaccine - Lessons learned","author":"Shendale","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0060","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw564","article-title":"Regulatory aspects of Sabin type 2 withdrawal from trivalent oral poliovirus vaccine: Process and lessons learned","author":"Decina","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0061","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix059","article-title":"Communications, immunization, and polio vaccines: Lessons from a global perspective on generating political will, informing decision-making and planning, and engaging local support","author":"Menning","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0062","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw571","article-title":"Managing the planned cessation of a global supply market: Lessons learned from the global cessation of the trivalent oral poliovirus vaccine market","author":"Rubin","year":"2017; 216 ( 1):40\u20135.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0063","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw550","article-title":"A supply and demand management perspective on the accelerated global introductions of Inactivated Polio Vaccine in a constrained supply market","author":"Lewis","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0064","article-title":"Lessons Learned from managing the planning and implementation of IPV introduction in support of the Polio Endgame","author":"Zipursky","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0065","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw574","article-title":"Experience with IPV Introduction and the \u201cSwitch\u201d from Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization\u2019s Western Pacific Region","author":"Gurung","year":"2017; 216 ( 1):101\u20138.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0066","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw602","article-title":"The switch from trivalent to bivalent oral poliovirus vaccine in the South-East Asia Region","author":"Bahl","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0067","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix133","article-title":"Introduction of inactivated polio vaccine, withdrawal of type 2 oral polio vaccine, and routine immunization strengthening in the Eastern Mediterranean Region","author":"Fahmy","year":"2017; 216 ( 1):86\u201393.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0068","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw557","article-title":"Systematization of the introduction of IPV and switch from tOPV to bOPV in the Americas","author":"Pedreira","year":"2017; 216 ( 1):76\u201385.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0069","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw616","article-title":"Introduction of inactivated poliovirus vaccine and trivalent oral polio vaccine\/bivalent oral polio vaccine switch in the African Region","author":"Tevi-Benissan","year":"2017; 216 ( 1):66\u201375.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0070","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw601","article-title":"The role of national immunization advisory groups (NITAGs) in the introduction of inactivated polio vaccine: experience of the Indonesia and Uganda NITAGs","author":"Ba-Nguz","year":"2017; 216 ( 1):109\u201313.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0071","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw544","article-title":"Succeeding in new vaccine introduction: lessons learned from the introduction of inactivated poliovirus vaccine in Cameroon, Kenya and Nigeria","author":"Scotney","year":"2017; 216 ( 1):130\u20136.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0072","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw591","article-title":"Cold chain adaptability during introduction of inactivated polio vaccine in Bangladesh, 2015","author":"Billah","year":"2017; 216 ( 1):114\u201321.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0073","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw510","article-title":"Lessons learned from the introduction of inactivated poliovirus vaccine (IPV) in Bangladesh","author":"Estivariz","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0074","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw570","article-title":"Acceptance of the administration of multiple injectable vaccines in a single immunization visit in Albania","author":"Preza","year":"2017; 216 ( 1):146\u201351.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0075","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix054","article-title":"Administering multiple injectable vaccines during a single visit\u2014summary of findings from the accelerated introduction of inactivated polio vaccine globally","author":"Dolan","year":"2017; 216 ( 1):152\u201360.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0076","first-page":"261","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2015: conclusions and recommendations","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0077","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw626","article-title":"Implementing the synchronized global switch from trivalent to bivalent oral polio vaccines\u2014lessons learned from the global perspective","author":"Ramirez Gonzalez","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0078","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw558","article-title":"Monitoring and validation of the global replacement of tOPV with bOPV, April\u2013May 2016","author":"Farrell","year":"2017; 216 ( 1):193\u2013201.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0079","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw572","article-title":"Disposing of excess vaccines after the withdrawal of oral polio vaccine","author":"Wanyoike","year":"2017; 216 ( 1):202\u20138.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0080","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw635","article-title":"Monitoring results in routine immunization: Development of routine immunization dashboard in selected African countries in the context of the Polio Eradication Endgame Strategic Plan","author":"Poy","year":"2017; 216 ( 1):226\u201336.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0081","article-title":"Contribution of global polio eradication initiative\u2013funded personnel to the strengthening of routine immunization programs in the 10 focus countries of the polio eradication and endgame strategic plan","author":"van den Ent","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0082","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix068","article-title":"Legacy of polio\u2014use of india\u2019s social mobilization network for strengthening of the universal immunization program in india","author":"Deutsch","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0083","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw520","article-title":"Use of dedicated mobile teams and polio volunteer community mobilizers to increase access to zero-dose oral poliovirus vaccine and routine childhood immunizations in settlements at high risk for polio transmission in northern nigeria","author":"Ongwae","year":"2017; 216 ( 1):267\u201372.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0084","article-title":"Experiences and lessons from polio eradication applied to immunization in ten focus countries of the polio endgame strategic plan","author":"van den Ent","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0085","article-title":"Transition planning for after polio eradication","author":"Rutter","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0086","unstructured":"Strategic Advisory Group of Experts on Immunization. 2016 midterm review of the Global Vaccine Action Plan.http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/october\/1_Draft_GVAP_Assessment_report_2016_for_Yellow_Book_28_Sep_2016.pdf. Accessed 27 February 2017."},{"key":"key\n\t\t\t\t20180306121629_CIT0087","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw593","article-title":"Using acute flaccid paralysis surveillance as a platform for vaccine preventable disease surveillance","author":"Wassilak","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0088","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix077","article-title":"Expansion of surveillance for vaccine-preventable diseases: building on the global polio laboratory network and the global measles and rubella laboratory network platforms","author":"Mulders","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0089","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix092","article-title":"The global polio laboratory network as a platform for the viral vaccine-preventable and emerging diseases laboratory networks","author":"Diop","year":"2017; 216 ( 1):299\u2013307.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0090","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix112","article-title":"Transitioning lessons learned and assets of the global polio eradication initiative to global and regional measles and rubella elimination","author":"Kretsinger","year":"2017; 216 ( 1):308\u201315.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0091","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix014","article-title":"Polio legacy in action: using the polio eradication infrastructure for measles elimination in Nigeria\u2014the national stop transmission of polio program","author":"Michael","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0092","article-title":"Mapping for health in Cameroon: polio legacy and beyond","author":"Rosencrans","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0093","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw546","article-title":"Placing human behavior at the center of the fight to eradicate polio: lessons learned and their application to other life-saving interventions","author":"Guirguis","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0094","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw563","article-title":"Using the Stop Transmission of Polio (STOP) program to develop a South Sudan expanded program on immunization workforce","author":"Tchoualeu","year":"2017; 216 ( 1):362\u20137.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0095","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix163","article-title":"Lessons learned and legacy of the stop transmission of polio program","author":"Kerr","year":"2017; 216 ( 1):316\u201323.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0096","first-page":"561","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 - conclusions and recommendations","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180306121629_CIT0097","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","author":"Okayasu","year":"2017; 216 ( 1):161\u20137.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0098","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15585\/mmwr.mm6533a5","article-title":"Fractional-dose inactivated poliovirus vaccine immunization campaign\u2014Telangana State, India, June 2016","volume":"65","author":"Bahl","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306121629_CIT0099","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.15585\/mmwr.mm6552a9","article-title":"Notes from the field: detection of Sabin-like type 2 poliovirus from sewage after global cessation of trivalent oral poliovirus vaccine\u2014Hyderabad and Ahmedabad, India, August\u2013September 2016","volume":"65","author":"Bahl","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180306121629_CIT0100","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix105","article-title":"Considerations for the full global withdrawal of oral polio vaccine after eradication of polio","author":"Hampton","year":"2017; 216 ( 1):217\u201325.","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306121629_CIT0101","unstructured":"Gavi, the Vaccine Alliance. New and underused vaccines support.http:\/\/www.gavi.org\/support\/nvs\/. Accessed 21 February 2017."}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_1\/S1\/24265066\/jix117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T10:26:53Z","timestamp":1601720813000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S1\/3935074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":101,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix117","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,7,1]]}}}